Arnnon Geshuri - Jul 27, 2023 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Stock symbol
TDOC
Transactions as of
Jul 27, 2023
Transactions value $
-$102,263
Form type
4
Date filed
7/28/2023, 04:11 PM
Previous filing
Jun 5, 2023
Next filing
Aug 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $10.2K +3.75K +4.94% $2.73* 79.7K Jul 27, 2023 Direct F1
transaction TDOC Common Stock Sale -$113K -3.75K -4.7% $30.00 76K Jul 27, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -3.75K -1.62% $0.00 228K Jul 27, 2023 Common Stock 3.75K $2.73 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 29, 2022.
F2 One-fourth of the option vested on December 4, 2018 and 1/48 of the option vested monthly thereafter.